Regulating IRS-proteins by Ser/Thr Phosphorylation
通过 Ser/Thr 磷酸化调节 IRS 蛋白
基本信息
- 批准号:7414864
- 负责人:
- 金额:$ 32.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAllelesAntibody FormationBuild-itCellsChronicComplexDataDiabetes MellitusDockingFundingGenesGenetic PolymorphismGoalsHomologous GeneHumanIRS1 geneIRS2 geneInflammationInsulinInsulin ResistanceJUN kinaseLibrariesLifeLinkLiteratureMediatingMetabolicMetabolic DiseasesMetabolic stressMetabolismMolecularMusN-terminalNon-Insulin-Dependent Diabetes MellitusNutrientPancreasPhospho-Specific AntibodiesPhosphorylationPhosphorylation SitePhosphotransferasesPlayProcessProductionProteinsPublicationsRegulationRiskRodentRoleSerine/Threonine PhosphorylationSignal PathwaySignal TransductionSignaling ProteinSiteSorting - Cell MovementSourceStreamTissuesTyrosine PhosphorylationUnited States National Institutes of HealthValidationcell growthcytokinehuman IRS2 proteininsulin receptor substrate 1 proteininsulin receptor tyrosine kinaseinsulin sensitivityinsulin signalinglink proteinmutantprototyperesponse
项目摘要
DESCRIPTION (provided by applicant): This application entitled "Regulating IRS-proteins by Ser/Thr Phosphorylation" is the amened competing renewal ofDK38712-16. IRS1 is a prototype docking protein that links the activated insulin receptor tyrosine kinase to down-stream signaling pathways. Tyrosine phosphorylation of IRS 1, and its homolog IRS2, activates the PI3K and ras/MAPK cascades, which promote cellular growth, survival and metabolism. Nutrient excess, acute and chronic inflammation, or proinflammatory cytokines regulate IRS-protein signaling through multisite Ser/Thr-phosphorylation. During the previous funding period, we revealed the inhibitory role of Ser307 phosphorylation in rodent IRS1 (Ser312 in human IRS1), and showed the utility of polyclonal phosphospecific antibodies to study these processes in murine and human cells and tissues. Phosphorylation of Ser307 is mediated, at least in part, by the association of the activated NH2-terminal JUN kinase (JNK) with IRS1, linking insulin signaling to the inhibitory effects of metabolic stress and proinflammatory cytokines. IRS1and IRS2 each contain at least 40 Ser/Thr-phosphorylation sites (probably more), but how they interact to regulate insulin action in various tissues under acute and chronic metabolic stress is important to resolve. Here, we propose 5 Specific Aims to reveal how Ser/Thr-phosphorylation of Irs1 and Irs2 modulates insulin sensitivity and contirbutes to life threatening metabolic diseases that can progress to diabetes. 1. Prepare and validate a comprehensive mAb library against observed S/T-phosphorylation sites in Irs1 and Irs2 (apS/TmAbIrs1 and apS/TmAbIrs2 libraries). Support is requested in year 1 to generate the library against Irs1 (apS/TmAbIrs1); the apS/TmAbIrs2 library already underway and supported by other sources. 2. Utilize the pS/TmAblrs1 and pS/TmAbIrs2 libraries to decode the S/T-phosphorylation that occurs on Irs1 and Irs2 during metabolic stress. 3. Investigate the regulatory function of Ser307 in Irs1 using mice in which the Irs1 alleles are replaced with mutant A307Irs1 alleles. 4. Determine whether Ser302 in Irsl plays a positive or negative regulatory role upon Irsl signaling in murine tissues. 5. Establish the role of the Jnk-directed "kinase interaction motif (KIM) in Irsl. This proposal is important because dysregulated insulin signaling contributes to life threatening metabolic disease that progresses to type 2 diabetes when pancreatic b-cells fail to secrete sufficient insulin quickly enough to compensate for insulin resistance. Ser/Thr-phosphorylation of Irs 1 and Irs2 is common cause of insulin resistance. The production and validation of the apS/TmAbIrs1 and apS/TmAbIrs2 libraries to detect and quantify the phosphorylation sites provides a rational experimental platform to decoding the complex regulatory mechanism that controls the insulin response throughout life.
描述(由申请人提供):此申请名为“通过Ser/Thr磷酸化调节IRS蛋白质”是AMENED竞争的续订DK38712-16。 IRS1是一种原型对接蛋白,将活化的胰岛素受体酪氨酸激酶与下游信号通路联系起来。 IRS 1及其同源性IRS2的酪氨酸磷酸化激活了PI3K和RAS/MAPK级联反应,从而促进细胞生长,生存和代谢。营养过量,急性和慢性炎症或促炎细胞因子通过多站点SER/THR磷酸化调节IRS-蛋白质信号。在上一个资金期间,我们揭示了Ser307磷酸化在啮齿动物IRS1中的抑制作用(人类IRS1中的Ser312),并显示了多克隆磷酸特异性抗体在鼠类和人类细胞和人类细胞和组织中研究这些过程的实用性。 Ser307的磷酸化至少部分是由活化的NH2-末端JUN激酶(JNK)与IRS1的关联介导的,将胰岛素信号与代谢胁迫和促炎细胞因子的抑制作用联系起来。 IRS1和IRS2每个都包含至少40个Ser/Thr磷酸化位点(可能更多),但是它们如何相互作用以调节急性和慢性代谢应激下各种组织中的胰岛素作用对于解决方案很重要。在这里,我们提出了5个特定旨在揭示IRS1和IRS2的Ser/Thr-磷酸化如何调节胰岛素敏感性和对威胁生命的代谢性疾病的敏感性,从而可以发展为糖尿病。 1。准备并验证IRS1和IRS2(APS/TMABIRS1和APS/TMABIRS2库)中观察到的S/T磷酸化位点的综合MAB文库。在第1年要求支持IRS1(APS/TMABIRS1)的库; APS/TMABIRS2库已经在进行中,并得到了其他来源的支持。 2。利用PS/TMABLRS1和PS/TMABIRS2库来解码代谢应力期间IRS1和IRS2上发生的S/T磷酸化。 3。使用小鼠使用IRS1等位基因代替突变体A307IRS1等位基因的小鼠研究Ser307的调节功能。 4。确定IRSL中的Ser302在鼠组织中IRSL信号传导上是否扮演正调控作用。 5。建立IRSL中JNK定向的“激酶相互作用基序(KIM)的作用。该提案很重要,因为失调的胰岛素信号失调会导致威胁生命的代谢疾病,该疾病会导致2型糖尿病的发展,而当胰腺B-cells不足以使1次胰岛素足够弥补的胰岛素及其胰岛素的胰岛素共同促进胰岛素的共同点。胰岛素抵抗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Morris F. White其他文献
Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
生长激素对胰腺 β 细胞增殖的刺激是葡萄糖依赖性的:通过 janus 激酶 2 (JAK2)/信号转导器和转录激活剂 5 (STAT5) 进行信号转导,与胰岛素受体底物介导的有丝分裂信号传导没有串扰。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:4.1
- 作者:
S. P. Cousin;S. Hügl;M. G. Myers;Morris F. White;Anne Reifel;Christopher J. Rhodes - 通讯作者:
Christopher J. Rhodes
The IRS-Pathway Operates Distinctively From the Stat-Pathway in Hematopoietic Cells and Transduces Common and Distinct Signals During Engagement of the Insulin or Interferon-α Receptors
- DOI:
10.1182/blood.v90.7.2574 - 发表时间:
1997-10-01 - 期刊:
- 影响因子:
- 作者:
Shahab Uddin;Eleanor N. Fish;Dorie Sher;Concetta Gardziola;Oscar R. Colamonici;Merrill Kellum;Paula M. Pitha;Morris F. White;Leonidas C. Platanias - 通讯作者:
Leonidas C. Platanias
Early biochemical events in insulin-stimulated fluid phase endocytosis
胰岛素刺激的液相内吞作用的早期生化事件
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
D. Pitterle;R. Sperling;M. G. Myers;Morris F. White;P. J. Blackshear - 通讯作者:
P. J. Blackshear
Insulin Receptor Substrate-l Mediates Phosphatidylinositol 3”Kinase and ~ 7 0 ~ ~ ~ Signaling during Insulin, Insulin-like Growth Factor-1, and Interleukin-4 Stimulation*
胰岛素受体底物-l 在胰岛素、胰岛素样生长因子-1 和白介素-4 刺激过程中介导磷脂酰肌醇 3 激酶和 ~ 7 0 ~ ~ ~ 信号传导*
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Jr.§ Martin G. Myers;Timothy C. Grammea;LingMei Wangll;Xiao Jian;Jacalyn H. Piercell;John BlenisW;Morris F. White - 通讯作者:
Morris F. White
Insulin-induced <em>egr-1</em> and c-<em>fos</em> expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
- DOI:
10.1074/s0021-9258(19)67421-1 - 发表时间:
1997-01-31 - 期刊:
- 影响因子:
- 作者:
Shuko Harada;Robert M. Smith;Judith A. Smith;Morris F. White;Leonard Jarett - 通讯作者:
Leonard Jarett
Morris F. White的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Morris F. White', 18)}}的其他基金
Regulation of hippocampal function by central and peripheral IRS signaling
通过中枢和外周 IRS 信号调节海马功能
- 批准号:
10343848 - 财政年份:2020
- 资助金额:
$ 32.16万 - 项目类别:
Regulation of hippocampal function by central and peripheral IRS signaling
通过中枢和外周 IRS 信号调节海马功能
- 批准号:
10162475 - 财政年份:2020
- 资助金额:
$ 32.16万 - 项目类别:
Regulation of hippocampal function by central and peripheral IRS signaling
通过中枢和外周 IRS 信号调节海马功能
- 批准号:
10548150 - 财政年份:2020
- 资助金额:
$ 32.16万 - 项目类别:
Hepatic insulin resistance integrates T2D and NAFLD
肝脏胰岛素抵抗整合了 T2D 和 NAFLD
- 批准号:
10792348 - 财政年份:2013
- 资助金额:
$ 32.16万 - 项目类别:
Hepatic insulin resistance and metabolic disease
肝脏胰岛素抵抗与代谢疾病
- 批准号:
8482791 - 财政年份:2013
- 资助金额:
$ 32.16万 - 项目类别:
Hepatic insulin resistance and metabolic disease
肝脏胰岛素抵抗与代谢疾病
- 批准号:
8637073 - 财政年份:2013
- 资助金额:
$ 32.16万 - 项目类别:
Metabolic Crosstalk During Hepatic Insulin Resistance
肝脏胰岛素抵抗期间的代谢串扰
- 批准号:
9749986 - 财政年份:2013
- 资助金额:
$ 32.16万 - 项目类别:
Hepatic insulin resistance and metabolic disease
肝脏胰岛素抵抗与代谢疾病
- 批准号:
8829241 - 财政年份:2013
- 资助金额:
$ 32.16万 - 项目类别:
Metabolic Crosstalk During Hepatic Insulin Resistance
肝脏胰岛素抵抗期间的代谢串扰
- 批准号:
9982302 - 财政年份:2013
- 资助金额:
$ 32.16万 - 项目类别:
Gordon Conference: Second Messengers and Phosphorylation
戈登会议:第二信使和磷酸化
- 批准号:
6535541 - 财政年份:2002
- 资助金额:
$ 32.16万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia
肝素诱导的血小板减少症发病机制中的 ABO 和免疫遗传学变异
- 批准号:
10653005 - 财政年份:2022
- 资助金额:
$ 32.16万 - 项目类别:
ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia
肝素诱导的血小板减少症发病机制中的 ABO 和免疫遗传学变异
- 批准号:
10439313 - 财政年份:2022
- 资助金额:
$ 32.16万 - 项目类别:
Impact of HLA-II Adaptation on CD4 T-cell and Tfh responses in HIV-1 Vaccination
HIV-1 疫苗接种中 HLA-II 适应对 CD4 T 细胞和 Tfh 反应的影响
- 批准号:
10254574 - 财政年份:2021
- 资助金额:
$ 32.16万 - 项目类别:
Impact of HLA-II Adaptation on CD4 T-cell and Tfh responses in HIV-1 Vaccination
HIV-1 疫苗接种中 HLA-II 适应对 CD4 T 细胞和 Tfh 反应的影响
- 批准号:
10616602 - 财政年份:2021
- 资助金额:
$ 32.16万 - 项目类别: